arrow
M

María Flores-López

universidad de malaga
H指数:9
被引数:224

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Co-designed web platform (TeenFit) to identify physical activity mobile apps for Spanish adolescents: a study protocol

协同设计的网络平台(TeenFit)用于识别西班牙青少年物理活动移动应用程序:一项研究方案

2026-04-280
PRE
Chemokines and Motor Symptoms in First-Episode Psychosis: Are We Overlooking One of the Puzzle Pieces in Understanding the Neurological Immune Mechanisms behind Them?

趋化因子和首发精神分裂症的运动症状:我们是否在理解其背后的神经免疫机制时忽略了拼图中的一块?

2025-12-010
PRE
Sex-specific dysregulation of the CX3CL1/CX3CR1 Axis following cocaine exposure: Translational evidence for a potential biomarker of abstinence

性特异性CX3CL1/CX3CR1轴在可卡因暴露后的失调:戒断潜在生物标志物的转化证据

2025-08-310
PREAI
Exploratory study on plasma Acylglycerol and Acylethanolamide dysregulation in substance use and attention-deficit/hyperactivity disorder: Implications for novel biomarkers in dual diagnosis

探索性研究:物质使用障碍与注意缺陷多动障碍中血浆酰基甘油和酰基乙醇酰胺失调及其对共病诊断新型生物标志物的启示

2025-04-010
OAAI
Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders (vol 13, 215, 2023)
2024-09-170
OAAI
Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study
TOXICS
IF4.1
2024-02-292
OAAI
Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
2023-06-212
OAAI
Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
2023-01-071
OAAI
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder

血管内皮生长因子作为酒精使用障碍患者神经炎症和额叶认知障碍的潜在生物标志物

2022-04-2012
OAAI
Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease
2021-09-137
OAAI